Teradyne TodayTERTeradyne$104.16 -3.27 (-3.04%) 52-Week Range$65.77▼$144.16Dividend Yield0.46%P/E Ratio36.04Price Target$114.44Add to WatchlistThe stock market often sends investors subtle hints, but on July 30, 2025, its message about Teradyne, Inc. NASDAQ: TER was loud and clear. Shares of the semiconductor test equipment supplier rose higher, closing the day with a nearly 19% gain. Teradyne’s stock price climb seemed to be a decisive response to the company’s latest earnings report.Get Teradyne alerts:I ...

Core Insights - The AI megatrend is not limited to tech stocks but is influencing all sectors, including transportation, telecom, fast food, and finance [2][3] - Investors must evaluate their portfolios through the lens of AI, as it is a critical factor for growth and operational efficiency [3][6] AI Market Trends - President Trump's AI Action Plan aims to reduce regulatory hurdles and invest billions to maintain U.S. leadership in AI development [8] - Estimates suggest that generative AI could contribute between $2.6 trillion and $4.4 trillion annually to the economy, with Goldman Sachs predicting a $7 trillion increase in global GDP over the next decade [15] Company Performance - Palantir (PLTR) has seen an 81% increase in stock value this year, driven by its focus on AI and data analytics [11][10] - Coherent (COHR), recommended as an AI builder stock, has rebounded over 70% since being identified as oversold, with strong growth prospects [13][14] Robotics and Automation - The global population of industrial robots is expected to grow from over 4 million to more than 6 million within three years, indicating a significant trend in automation [17] - Teradyne (TER) is positioned to benefit from AI-driven automation and has already seen over a 10% increase since its recommendation in early July [19]

证 券 研 究 报 告 泰瑞达（TER）FY25Q2 业绩点评及业绩说明会纪要 25Q2 营收超过指引中值，AI 需求带动下半 年指引乐观 ❖ 事项： 2025 年 7 月 29 日泰瑞达发布 2025 年 Q2 季度报告，并召开业绩说明会。公司 财务季度 FY2025Q2 截至 2025 年 6 月 30 日，即自然季度 CQ2025Q2。2025Q2， 公司实现营收 6.52 亿美元，同比下滑 10.68%，环比下滑 4.96%；毛利率为 57.3%，同比下滑 1pct，环比下滑 3.3pct。 技术研发不及预期，扩产不及预期，下游需求不及预期，贸易摩擦。 ❖ 会议纪要 电子 2025 年 08 月 02 日 会议时间：2025 年 7 月 29 日 会议地点：线上 ❖ 评论： 1. 业绩总览：2025Q2，公司实现营业收入 6.52 亿美元（YoY-10.68%，QoQ- 4.96%），超过指引中值；毛利率为 57.3%（YoY-1pct，QoQ-3.3pct），接近指引 上沿；净利润为 0.78 亿美元（YoY-57.92%,QoQ-20.73%）。25Q2 末库存金额 3.51 亿美元（YoY+21 ...

Group 1 - China Biopharmaceutical (1177.HK) saw a rise of over 3% after announcing a successful licensing agreement with Merck for its PD-1/VEGF dual antibody, expecting a $300 million milestone payment soon [1] - CSPC Pharmaceutical Group (1093.HK) increased by over 5% following the announcement of an exclusive licensing agreement with Madrigal Pharmaceuticals for the global development of its GLP-1 receptor agonist SYH2086 [1] - Youzan (8083.HK) surged over 7% as it projected a revenue of approximately 709 to 719 million RMB for the first half of the year, a year-on-year increase of about 3.3% to 4.8%, and a net profit of 68 to 74 million RMB, marking a turnaround from a loss last year [1] Group 2 - Xingsheng International (6058.HK) rose nearly 18% after the bank announced its commitment to embrace technological transformation and explore stablecoins and AI initiatives [2] - New Oriental Education (9901.HK) fell nearly 4% after reporting a 9.4% year-on-year increase in net revenue to $1.243 billion for the fourth quarter of fiscal year 2025, but a 73.7% drop in net profit [2] - Kingdee International (0268.HK) saw a rise of over 7% as it announced a board meeting to review its interim results and potential dividend distribution [2] Group 3 - Macau gaming stocks rose, with MGM China (2282.HK) up over 4% after Macquarie raised its forecast for Macau's total gaming revenue for 2025 by 5% to 235.7 billion RMB, indicating a year-on-year growth of 4% [3] - Gold stocks in Hong Kong continued to decline, with Tongguan Gold (0340.HK) dropping over 9% for six consecutive days, as spot gold prices fell below $3,270 per ounce [4] - Kangfang Biopharma (9926.HK) rose nearly 5% after announcing the completion of the first patient dosing in a pivotal clinical trial for its PD-1/VEGF dual-specific antibody [4] Group 4 - Weishi Jiajie (0856.HK) increased by over 3% as a report indicated that its Southeast Asia business is expected to see a significant revenue increase of 74% in 2024, with net profit contributing about 51% [5] Group 5 - Meta (META.US) exceeded revenue expectations and provided strong guidance for the current quarter, leading to an after-hours increase of over 11% [6] - Microsoft (MSFT.US) reported an 18% year-on-year growth in revenue, driven by its cloud business, with Azure revenue up 34% for the full year, resulting in an after-hours increase of over 8% [6] - Wingstop (WING.US) surged by 26.85% after reporting adjusted earnings per share of $1.00 for the second quarter, exceeding analyst expectations [6] Group 6 - Several biopharmaceutical stocks surged, with Replimune (REPL.US) up 101.33% following news of regulatory changes at the FDA that may ease pressure on gene therapy and vaccine companies [7] - Marvell Technology (MRVL.US) rose 7.07% after announcing a partnership with Rebellions to provide AI systems for regional projects in Asia-Pacific and the Middle East [7] - Palo Alto Networks (PANW.US) fell 5.58% after agreeing to acquire CyberArk Software for approximately $25 billion [8]

Shares of Teradyne paced S&P 500 advancers Wednesday, a day after the automatic test equipment manufacturer posted strong second-quarter results, led by gains in its Semiconductor Test Group. https://t.co/aYdbqcdCeR ...

Core Insights - Teradyne (TER) reported second-quarter 2025 non-GAAP earnings of 57 cents per share, exceeding the Zacks Consensus Estimate by 5.56% but down 33.7% year over year [1] - Revenues for the quarter were $652 million, surpassing the Zacks Consensus Estimate by 0.89% but declining 10.7% year over year [1] Revenue Breakdown - Revenue from Semiconductor Test platforms was $492 million (75.5% of total revenues), System Test business generated $75 million (11.5%), and Robotics and Product Test contributed $85 million (13%) [2] Margin and Expenses - Non-GAAP gross margin for the quarter was 57.3%, a contraction of 110 basis points year over year [2] - Selling and administrative expenses rose 2.1% year over year to $157.8 million, accounting for 24.2% of revenues, an increase of 300 basis points [3] - Engineering and development expenses increased 5.9% year over year to $118.4 million, representing 18.2% of revenues, up 280 basis points [3] Operating Income - Non-GAAP operating income fell 38.5% year over year to $98.2 million, with the operating margin contracting 680 basis points to 15.1% [4] Balance Sheet and Cash Flow - As of June 29, 2025, Teradyne's cash and cash equivalents were $367.9 million, down from $507.8 million as of March 30, 2025 [5] - Net cash provided by operating activities in the reported quarter was $182.1 million [5] - The board authorized an expansion of the share repurchase program, increasing the target to $1 billion by the end of 2026 [5] Q3 Guidance - For Q3 2025, Teradyne expects revenues between $710 million and $770 million, with the Zacks Consensus Estimate at $764.4 million, indicating 3.7% growth year over year [6] - Non-GAAP earnings are projected to be between 69 cents and 87 cents per share, with the Zacks Consensus Estimate at 91 cents per share, suggesting 1.1% growth year over year [7] Zacks Rank and Comparisons - Teradyne currently holds a Zacks Rank 3 (Hold) [8] - Comparatively, Arista Networks (ANET) has a Zacks Rank 1 (Strong Buy), while Leidos (LDOS) and Enovix Corporation (ENVX) hold Zacks Rank 2 (Buy) [8]

首席执行官Greg Smith表示，泰瑞达的半导体测试业务表现优于预期，销售额达到4.92亿美元。其针对 人工智能应用设计的系统级芯片产品是最大的增长驱动力。对今年剩余时间的展望已经明朗，计算、网 络和存储领域的需求正在增强。"我们认为人工智能将推动泰瑞达在下半年实现强劲表现。"Smith说。 智通财经APP获悉，周三，泰瑞达(TER.US)大涨超18%，创4个月新高，报107.11美元。消息面上，泰瑞 达第二季度业绩超出分析师预期，主要得益于强劲的半导体测试设备销售和需求改善。该公司第二季度 利润为7840万美元，即每股收益49美分，而去年同期为1.863亿美元，即每股收益1.14美元。剔除某些一 次性项目后，调整后每股收益为57美分，高于FactSet分析师预测的54美分。营业收入下降11%至6.518 亿美元，FactSet调查的分析师预测营业收入为6.506亿美元。 ...

Teradyne (TER) Q2 2025 Earnings Call July 30, 2025 08:30 AM ET Company ParticipantsTraci Tsuchiguchi - VP - Corporate AffairsGreg Smith - President, CEO & DirectorSanjay Mehta - VP & CFOCJ Muse - Senior Managing DirectorTimothy Arcuri - Managing DirectorVivek Arya - Managing DirectorAtif Malik - Director - Technology Equity ResearchKrish Sankar - Managing DirectorBrian Chin - DirectorSteve Barger - MD - Equity ResearchGus Richard - Managing Director David Duley - Managing PrincipalConference Call Participan ...

Teradyne (TER) Q2 2025 Earnings Call July 30, 2025 08:30 AM ET Speaker0and welcome to the Q2 twenty twenty five Teradyne Inc. Earnings Conference Call. At this time, all participants are in listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded.I would now like to turn the conference over to your host, Tracy Sushi Gucci. Please go ahead.Speaker1Thank you, operator. Good morning, everyone, and welcome to our discussion of Teradyne ...

Financial Results for Q2 2025 July 30, 2025 Safe Harbor Sales of $652M | Non-GAAP Gross Margin(1) of 57.3% | Non-GAAP EPS(1) of $0.57 | EPS Above Mid Guidance This presentation contains forward-looking statements including statements regarding Teradyne's future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," ...